TJP1 and colitis: Linghang Qu et al. demonstrated that atractylenolide I (50 mg/kg) could improve the induction of mucoprotein MUC2, tight junction proteins (ZO-1, Occludin), and inflammatory factors TNF-α, IL-6, IL-1β in DSS-induced colitis mice.